Nikhil Prasad Fact checked by:Thailand Medical News Team Oct 02, 2026 38 minutes ago
Moringa oleifera, widely known as the drumstick tree, may offer a powerful combination of antibacterial and anti-inflammatory effects, according to a new scientific review examining evidence on its leaves, stems, and bioactive compounds.
Moringa leaves contain bioactive compounds showing antibacterial and anti-inflammatory potential in
laboratory and animal research.
Researchers from the Yunnan Technology Innovation Center of Natural Rubber; Yunnan Key Laboratory of Sustainable Utilization Research on Rubber Tree; and Yunnan Institute of Tropical Crops, China conducted the review.
Moringa plant compounds attack bacteria in several ways
The review analyzed 134 references selected from PubMed/MEDLINE, Web of Science, Scopus, and Google Scholar. Moringa contains flavonoids, phenolic acids, isothiocyanates, sterols, and other compounds linked to biological activity.
Laboratory evidence indicates that leaf and stem extracts can inhibit both Gram-positive and Gram-negative pathogens, including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Enterococcus faecalis. Reported minimum inhibitory concentrations for many leaf and stem preparations were approximately 0.2–4 mg/mL, although results varied substantially between studies.
Particularly interesting was evidence that some Moringa compounds do more than directly inhibit bacterial growth. They may damage bacterial membranes, interfere with enzymes, reduce bacterial adhesion, disrupt quorum sensing, and inhibit biofilms.
Astragalin, for example, produced an IC50 of 490 μmol/L—about 0.22 mg/mL—against E. coli. Rutin, chlorogenic acid, and hyperoside also demonstrated activity. Astragalin additionally reduced initial bacterial adhesion and biofilm formation while compromising membrane integrity.
Moringa may also calm inflammatory pathways
As highlighted in this
Thailand Medical News report, the review found that Moringa compounds may simultaneously influence pathways responsible for inflammation and oxidative stress.
Moringin, an isothiocyanate, has been associated with activation of the protective Nrf2/Keap1 pathway and inhibition of NF-κB signaling. Flavonoids including quercetin and kaempferol may also reduce inflammatory cytokines and inhibit COX and LOX enzymes.
Animal findings add another layer of interest. In rats with infected diabetic ulcers, leaf-extract treatment reduced bacterial burden and inflammatory TNF-α and IL-1β, increased anti-inflammatory IL-10, and accelerated wound closure. However, researchers emphasized that this does not prove antibacterial and anti-inflammatory effects act synergistically.
Human evidence remains limited
Despite encouraging laboratory and animal findings, clinical translation remains at an early stage. No large multicenter randomized double-blind trial has established Moringa leaves or stems as an effective treatment for inflammatory or infectious disease. Existing hum
an research has largely examined nutrition and metabolic outcomes rather than these clinical endpoints.
Conclusions
Moringa therefore represents an intriguing source of compounds capable of targeting bacteria, inflammation, and oxidative stress through multiple mechanisms. However, standardized preparations, stronger pharmacokinetic and safety evidence, direct synergy experiments, and well-designed human clinical trials are essential before these laboratory findings can support established medical treatments.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/19/8633
Read Also:
https://www.thailandmedical.news/articles/herbs-and-phytochemicals
Share
Tweet
Share
